ReviewPatient preference and adherence2017

Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability.

Michael S Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.